XML 35 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
12. Segments
9 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segments

12. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

   Nine Months Ended December 31, 
   2018   2017 
Revenues:        
Aethlon  $149,625   $74,813 
ESI        
Total Revenues  $149,625   $74,813 
           
Operating Losses:          
Aethlon  $(4,304,082)  $(3,495,189)
ESI   (104,017)   (64,860)
Total Operating Loss  $(4,408,099)  $(3,560,049)
           
Net Losses:          
Aethlon  $(4,469,399)  $(4,308,807)
ESI   (104,017)   (64,860)
Net Loss Before Non-Controlling Interests  $(4,573,416)  $(4,373,667)
           
Cash:          
Aethlon  $4,824,225   $5,610,061 
ESI   676    738 
Total Cash  $4,824,901   $5,610,799 
           
Total Assets:          
Aethlon  $4,950,079   $5,745,031 
ESI   676    5,723 
Total Assets  $4,950,755   $5,750,754 
           
Capital Expenditures:          
Aethlon  $   $23,705 
ESI        
Capital Expenditures  $   $23,705 
           
Depreciation and Amortization:          
Aethlon  $24,756   $27,402 
ESI        
Total Depreciation and Amortization  $24,756   $27,402 
           
Interest Expense:          
Aethlon  $(165,317)  $(306,495)
ESI        
Total Interest Expense  $(165,317)  $(306,495)